Article Text

Download PDFPDF
A case of early-stage epithelial ovarian cancer in pregnancy
  1. G. Otton1,
  2. S. Higgins2,
  3. K. A. Phillips1,3 and
  4. M. Quinn1
  1. 1Oncology/Dysplasia Unit and
  2. 2Perinatal Unit, Royal Women's Hospital, Carlton;
  3. 3Department of Haematology and Medical Oncology, Peter MacCallum Cancer Institute, East Melbourne, Victoria, Australia
  1. Address correspondence and reprint requests to: Associate Professor Michael Quinn, MbChB, MGO, MRCP (UK), FRCOG, FRANZCOG, CGO, Director of Oncology/Dysplasia Unit, Royal Women's Hospital, 132 Grattan Street, Carlton, Victoria 3053, Australia. E-mail: michael.quinn{at}maynegroup.com.

Abstract

There are few reports in the literature of platinum-based chemotherapy administered in pregnancy. We present a case of serous adenocarcinoma of the ovary complicating pregnancy. Following laparotomy at 16 weeks of gestation, four cycles of cisplatin were administered prior to confinement at 32 weeks. There were no neonatal sequelae. We believe there is increasing evidence for the safe use of cisplatin in pregnancy.

  • adenocarcinoma
  • cisplatin
  • ovarian
  • pregnancy

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.